These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 26696535)

  • 1. Enhanced plasmid DNA production by enzyme-controlled glucose release and an engineered Escherichia coli.
    Ramírez EA; Velázquez D; Lara AR
    Biotechnol Lett; 2016 Apr; 38(4):651-7. PubMed ID: 26696535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering Escherichia coli to increase plasmid DNA production in high cell-density cultivations in batch mode.
    Borja GM; Meza Mora E; Barrón B; Gosset G; Ramírez OT; Lara AR
    Microb Cell Fact; 2012 Sep; 11():132. PubMed ID: 22992433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modified Escherichia coli B (BL21), a superior producer of plasmid DNA compared with Escherichia coli K (DH5alpha).
    Phue JN; Lee SJ; Trinh L; Shiloach J
    Biotechnol Bioeng; 2008 Nov; 101(4):831-6. PubMed ID: 18814292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmid DNA production with Escherichia coli GALG20, a pgi-gene knockout strain: fermentation strategies and impact on downstream processing.
    Gonçalves GA; Prather KL; Monteiro GA; Carnes AE; Prazeres DM
    J Biotechnol; 2014 Sep; 186():119-27. PubMed ID: 24995846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering of Escherichia coli strains for plasmid biopharmaceutical production: scale-up challenges.
    Gonçalves GA; Prather KL; Monteiro GA; Prazeres DM
    Vaccine; 2014 May; 32(24):2847-50. PubMed ID: 24598722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of growth rate on plasmid DNA production and metabolic performance of engineered Escherichia coli strains.
    Wunderlich M; Taymaz-Nikerel H; Gosset G; Ramírez OT; Lara AR
    J Biosci Bioeng; 2014 Mar; 117(3):336-42. PubMed ID: 24012107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing strategies to increase plasmid DNA production in Escherichia coli DH5α using batch culture.
    Islas-Lugo F; Vega-Estrada J; Alvis CA; Ortega-López J; Del Carmen Montes-Horcasitas M
    J Biotechnol; 2016 Sep; 233():66-73. PubMed ID: 27374404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced production of plasmid DNA by engineered Escherichia coli strains.
    Pablos TE; Soto R; Mora EM; Le Borgne S; Ramírez OT; Gosset G; Lara AR
    J Biotechnol; 2012 Apr; 158(4):211-4. PubMed ID: 21718724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of glucose import capacity in Escherichia coli: physiologic consequences and utility for improving DNA vaccine production.
    Fuentes LG; Lara AR; Martínez LM; Ramírez OT; Martínez A; Bolívar F; Gosset G
    Microb Cell Fact; 2013 May; 12():42. PubMed ID: 23638701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. De novo creation of MG1655-derived E. coli strains specifically designed for plasmid DNA production.
    Gonçalves GA; Prazeres DM; Monteiro GA; Prather KL
    Appl Microbiol Biotechnol; 2013 Jan; 97(2):611-20. PubMed ID: 22885693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of growth conditions on plasmid DNA production.
    Silva F; Passarinha L; Sousa F; Queiroz JA; Domingues FC
    J Microbiol Biotechnol; 2009 Nov; 19(11):1408-14. PubMed ID: 19996695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Segregated growth kinetics of Escherichia coli DH5α-NH36 in exponential-fed perfusion culture for pDNA vaccine production.
    Munguía-Soto R; García-Rendón A; Garibay-Escobar A; Guerrero-Germán P; Tejeda-Mansir A
    Biotechnol Appl Biochem; 2015; 62(6):795-805. PubMed ID: 25556882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automated fed-batch fermentation with feed-back controls based on dissolved oxygen (DO) and pH for production of DNA vaccines.
    Chen W; Graham C; Ciccarelli RB
    J Ind Microbiol Biotechnol; 1997 Jan; 18(1):43-8. PubMed ID: 9079287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering E. coli for improved microaerobic pDNA production.
    Jaén KE; Velazquez D; Delvigne F; Sigala JC; Lara AR
    Bioprocess Biosyst Eng; 2019 Sep; 42(9):1457-1466. PubMed ID: 31079222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of plasmid DNA yields during fed-batch culture of a fruR-knockout Escherichia coli strain.
    Ow DS; Yap MG; Oh SK
    Biotechnol Appl Biochem; 2009 Jan; 52(Pt 1):53-9. PubMed ID: 18380624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of an Escherichia coli strain engineered in the substrate uptake system for improved culture performance at high glucose and cell concentrations: an alternative to fed-batch cultures.
    Lara AR; Caspeta L; Gosset G; Bolívar F; Ramírez OT
    Biotechnol Bioeng; 2008 Mar; 99(4):893-901. PubMed ID: 17929322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiological effects of pH gradients on Escherichia coli during plasmid DNA production.
    Cortés JT; Flores N; Bolívar F; Lara AR; Ramírez OT
    Biotechnol Bioeng; 2016 Mar; 113(3):598-611. PubMed ID: 26301871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High crude violacein production from glucose by Escherichia coli engineered with interactive control of tryptophan pathway and violacein biosynthetic pathway.
    Fang MY; Zhang C; Yang S; Cui JY; Jiang PX; Lou K; Wachi M; Xing XH
    Microb Cell Fact; 2015 Jan; 14():8. PubMed ID: 25592762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rational engineering of Escherichia coli strains for plasmid biopharmaceutical manufacturing.
    Gonçalves GA; Bower DM; Prazeres DM; Monteiro GA; Prather KL
    Biotechnol J; 2012 Feb; 7(2):251-61. PubMed ID: 21913330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced Biosynthesis of Plasmid DNA from Escherichia coli Applying Experimental Design.
    Passarinha LA
    Methods Mol Biol; 2021; 2197():135-150. PubMed ID: 32827135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.